- Home
- IMVT vs NBTB Comparison
IMVT vs NBTB Comparison
Compare IMVT & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- NBTB
- Stock Information
- Founded
- IMVT N/A
- NBTB 1856
- Country
- IMVT United States
- NBTB United States
- Employees
- IMVT N/A
- NBTB N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- NBTB Major Banks
- Sector
- IMVT Health Care
- NBTB Finance
- Exchange
- IMVT Nasdaq
- NBTB Nasdaq
- Market Cap
- IMVT 2.5B
- NBTB 2.0B
- IPO Year
- IMVT N/A
- NBTB N/A
- Fundamental
- Price
- IMVT $14.85
- NBTB $41.85
- Analyst Decision
- IMVT Buy
- NBTB Buy
- Analyst Count
- IMVT 10
- NBTB 3
- Target Price
- IMVT $40.14
- NBTB $52.33
- AVG Volume (30 Days)
- IMVT 1.2M
- NBTB 321.4K
- Earning Date
- IMVT 05-29-2025
- NBTB 07-21-2025
- Dividend Yield
- IMVT N/A
- NBTB 3.25%
- EPS Growth
- IMVT N/A
- NBTB 17.05
- EPS
- IMVT N/A
- NBTB 3.03
- Revenue
- IMVT N/A
- NBTB $569,473,000.00
- Revenue This Year
- IMVT $108.88
- NBTB $26.51
- Revenue Next Year
- IMVT N/A
- NBTB $12.04
- P/E Ratio
- IMVT N/A
- NBTB $13.81
- Revenue Growth
- IMVT N/A
- NBTB 13.26
- 52 Week Low
- IMVT $12.72
- NBTB $34.47
- 52 Week High
- IMVT $34.47
- NBTB $52.44
- Technical
- Relative Strength Index (RSI)
- IMVT 50.48
- NBTB 43.88
- Support Level
- IMVT $13.79
- NBTB $40.91
- Resistance Level
- IMVT $15.22
- NBTB $42.74
- Average True Range (ATR)
- IMVT 0.69
- NBTB 0.87
- MACD
- IMVT 0.13
- NBTB -0.25
- Stochastic Oscillator
- IMVT 78.24
- NBTB 20.22
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.